Cargando…

Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study

The primary objectives of this study were to evaluate the effect of hearing implant (HI) use on quality of life (QoL) and to determine which QoL measure(s) quantify QoL with greater sensitivity in users of different types of HIs. Participants were adult cochlear implant (CI), active middle ear impla...

Descripción completa

Detalles Bibliográficos
Autores principales: Lassaletta, Luis, Calvino, Miryam, Sanchez-Cuadrado, Isabel, Skarzynski, Piotr Henryk, Cywka, Katarzyna B., Czajka, Natalia, Kutyba, Justyna, Tavora-Vieira, Dayse, van de Heyning, Paul, Mertens, Griet, Staecker, Hinrich, Humphrey, Bryan, Zernotti, Mario, Zernotti, Maximo, Magele, Astrid, Ploder, Marlene, Zabeu, Julia Speranza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909702/
https://www.ncbi.nlm.nih.gov/pubmed/35270201
http://dx.doi.org/10.3390/ijerph19052503
_version_ 1784666247236943872
author Lassaletta, Luis
Calvino, Miryam
Sanchez-Cuadrado, Isabel
Skarzynski, Piotr Henryk
Cywka, Katarzyna B.
Czajka, Natalia
Kutyba, Justyna
Tavora-Vieira, Dayse
van de Heyning, Paul
Mertens, Griet
Staecker, Hinrich
Humphrey, Bryan
Zernotti, Mario
Zernotti, Maximo
Magele, Astrid
Ploder, Marlene
Zabeu, Julia Speranza
author_facet Lassaletta, Luis
Calvino, Miryam
Sanchez-Cuadrado, Isabel
Skarzynski, Piotr Henryk
Cywka, Katarzyna B.
Czajka, Natalia
Kutyba, Justyna
Tavora-Vieira, Dayse
van de Heyning, Paul
Mertens, Griet
Staecker, Hinrich
Humphrey, Bryan
Zernotti, Mario
Zernotti, Maximo
Magele, Astrid
Ploder, Marlene
Zabeu, Julia Speranza
author_sort Lassaletta, Luis
collection PubMed
description The primary objectives of this study were to evaluate the effect of hearing implant (HI) use on quality of life (QoL) and to determine which QoL measure(s) quantify QoL with greater sensitivity in users of different types of HIs. Participants were adult cochlear implant (CI), active middle ear implant (VIBRANT SOUNDBRIDGE (VSB)), or active transcutaneous bone conduction implant (the BONEBRIDGE (BB)) recipients. Generic QoL and disease-specific QoL were assessed at three intervals: pre-activation, 6 months of device use, and 12 months of device use. 169 participants completed the study (110 CI, 18VSB, and 41BB). CI users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. On some device-specific measures, their QoL also significantly increased between 6 and 12 m device use. VSB users’ QoL significantly increased between all tested intervals with the disease-specific measure but not the generic measure. BB users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. In sum, HI users experienced significant postoperative increases in QoL within their first 12 m of device use, especially when disease-specific measures were used. Disease-specific QoL measures appeared to be more sensitive than their generic counterparts.
format Online
Article
Text
id pubmed-8909702
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89097022022-03-11 Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study Lassaletta, Luis Calvino, Miryam Sanchez-Cuadrado, Isabel Skarzynski, Piotr Henryk Cywka, Katarzyna B. Czajka, Natalia Kutyba, Justyna Tavora-Vieira, Dayse van de Heyning, Paul Mertens, Griet Staecker, Hinrich Humphrey, Bryan Zernotti, Mario Zernotti, Maximo Magele, Astrid Ploder, Marlene Zabeu, Julia Speranza Int J Environ Res Public Health Article The primary objectives of this study were to evaluate the effect of hearing implant (HI) use on quality of life (QoL) and to determine which QoL measure(s) quantify QoL with greater sensitivity in users of different types of HIs. Participants were adult cochlear implant (CI), active middle ear implant (VIBRANT SOUNDBRIDGE (VSB)), or active transcutaneous bone conduction implant (the BONEBRIDGE (BB)) recipients. Generic QoL and disease-specific QoL were assessed at three intervals: pre-activation, 6 months of device use, and 12 months of device use. 169 participants completed the study (110 CI, 18VSB, and 41BB). CI users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. On some device-specific measures, their QoL also significantly increased between 6 and 12 m device use. VSB users’ QoL significantly increased between all tested intervals with the disease-specific measure but not the generic measure. BB users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. In sum, HI users experienced significant postoperative increases in QoL within their first 12 m of device use, especially when disease-specific measures were used. Disease-specific QoL measures appeared to be more sensitive than their generic counterparts. MDPI 2022-02-22 /pmc/articles/PMC8909702/ /pubmed/35270201 http://dx.doi.org/10.3390/ijerph19052503 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lassaletta, Luis
Calvino, Miryam
Sanchez-Cuadrado, Isabel
Skarzynski, Piotr Henryk
Cywka, Katarzyna B.
Czajka, Natalia
Kutyba, Justyna
Tavora-Vieira, Dayse
van de Heyning, Paul
Mertens, Griet
Staecker, Hinrich
Humphrey, Bryan
Zernotti, Mario
Zernotti, Maximo
Magele, Astrid
Ploder, Marlene
Zabeu, Julia Speranza
Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study
title Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study
title_full Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study
title_fullStr Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study
title_full_unstemmed Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study
title_short Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study
title_sort using generic and disease-specific measures to assess quality of life before and after 12 months of hearing implant use: a prospective, longitudinal, multicenter, observational clinical study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909702/
https://www.ncbi.nlm.nih.gov/pubmed/35270201
http://dx.doi.org/10.3390/ijerph19052503
work_keys_str_mv AT lassalettaluis usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT calvinomiryam usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT sanchezcuadradoisabel usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT skarzynskipiotrhenryk usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT cywkakatarzynab usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT czajkanatalia usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT kutybajustyna usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT tavoravieiradayse usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT vandeheyningpaul usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT mertensgriet usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT staeckerhinrich usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT humphreybryan usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT zernottimario usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT zernottimaximo usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT mageleastrid usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT plodermarlene usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy
AT zabeujuliasperanza usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy